The Use of Technetium-99m for Intravital Tracing of Transplanted Multipotent Stromal Cells


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

We studied the possibility of in vivo tracing of multipotent mesenchymal stromal cells labeled with a radiophermaceutic preparation based on metastable isotope Technetium-99m and injected to rats with modeled traumatic brain injury. Accumulation of labeled cells occurred primarily in the liver and lungs. The cells distribution in internal organs greatly varied depending on the administration route. Cell injection into the carotid artery led to their significant accumulation in the damaged brain hemisphere, while intravenous injection was followed by diffuse cell distribution in all brain structures. Scintigraphy data were confirmed by magnetic resonance imaging and histological staining of cells. Visualization of stem cells labeled with Technetium-99m-based preparation by scintigraphy is an objective and highly informative method allowing real-time in vivo cell tracing in the body.

作者简介

D. Silachev

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow; Moscow

A. Kondakov

N. I. Pirogov National Russian Research Medical University, Ministry of Health of the Russian Federation; Hospital for Incurable Patients — Research Medical Rehabilitation Center

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow; Moscow

I. Znamenskii

N. I. Pirogov National Russian Research Medical University, Ministry of Health of the Russian Federation; Hospital for Incurable Patients — Research Medical Rehabilitation Center

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow; Moscow

Yu. Kurashvili

National Research Nuclear University MEPhI; P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow; Moscow

A. Abolenskaya

P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow

N. Antipkin

P. A. Hertsen Moscow Oncology Research Institute

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow

T. Danilina

A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow

V. Manskikh

A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow

M. Gulyaev

Laboratory of Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow

Yu. Pirogov

Laboratory of Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow

E. Plotnikov

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow; Moscow

D. Zorov

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation; A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University

编辑信件的主要联系方式.
Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow; Moscow

G. Sukhikh

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation

Email: zorov@genebee.msu.ru
俄罗斯联邦, Moscow

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media New York, 2016